Literature DB >> 16187771

Differences between minimally depressed patients who do and do not consider themselves to be in remission.

Mark Zimmerman1, Joseph B McGlinchey, Michael A Posternak, Michael Friedman, Daniela Boerescu, Naureen Attiullah.   

Abstract

OBJECTIVE: We recently derived a cutoff on a self-report scale corresponding to the most commonly used definition of remission in depression treatment studies (i.e., Hamilton Rating Scale for Depression [HAM-D] score < or = 7). However, recent research has suggested that use of this cutoff on the HAM-D to define remission is overinclusive. The goal of the present report from the Rhode Island Methods to Improve Diagnostic Assessment and Services (MIDAS) project was to examine how many depressed patients in ongoing treatment who are considered to be in remission by a self-report equivalent of the HAM-D definition of remission nonetheless do not consider themselves to be in remission.
METHOD: Five hundred thirty-five psychiatric outpatients treated for a DSM-IV major depressive episode were asked whether they considered themselves to be in remission and completed the Clinically Useful Depression Outcome Scale (CUDOS), a measure of the severity of the DSM-IV symptoms of depression. The study was conducted from August 2003 until July 2004.
RESULTS: Nearly one quarter of the patients who met the remission threshold on the CUDOS (55/249) did not consider themselves to be in remission. Among the CUDOS remitters, the total score on the CUDOS was significantly lower (p < .001) in patients who considered themselves to be in remission than in patients who did not indicate that they were in remission. Examination of specific symptoms revealed greater appetite disturbance and hypersomnia in the patients who did not think they were in remission.
CONCLUSIONS: Our results suggest that heterogeneity of clinical status exists even among patients who are minimally depressed and considered to be in remission according to contemporary definitions on symptom severity scales.

Entities:  

Mesh:

Year:  2005        PMID: 16187771     DOI: 10.4088/jcp.v66n0908

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  13 in total

1.  Hypersomnia subtypes, sleep and relapse in bipolar disorder.

Authors:  K A Kaplan; E L McGlinchey; A Soehner; A Gershon; L S Talbot; P Eidelman; J Gruber; A G Harvey
Journal:  Psychol Med       Date:  2014-12-17       Impact factor: 7.723

Review 2.  Hypersomnolence, Hypersomnia, and Mood Disorders.

Authors:  Lucie Barateau; Régis Lopez; Jean Arthur Micoulaud Franchi; Yves Dauvilliers
Journal:  Curr Psychiatry Rep       Date:  2017-02       Impact factor: 5.285

3.  Impaired neurobehavioral alertness quantified by the psychomotor vigilance task is associated with depression in the Wisconsin Sleep Cohort study.

Authors:  David T Plante; Erika W Hagen; Laurel A Ravelo; Paul E Peppard
Journal:  Sleep Med       Date:  2019-12-04       Impact factor: 3.492

4.  Altered slow wave activity in major depressive disorder with hypersomnia: a high density EEG pilot study.

Authors:  David T Plante; Eric C Landsness; Michael J Peterson; Michael R Goldstein; Tim Wanger; Jeff J Guokas; Giulio Tononi; Ruth M Benca
Journal:  Psychiatry Res       Date:  2012-04-16       Impact factor: 3.222

5.  Longitudinal associations of hypersomnolence and depression in the Wisconsin Sleep Cohort Study.

Authors:  David T Plante; Laurel A Finn; Erika W Hagen; Emmanuel Mignot; Paul E Peppard
Journal:  J Affect Disord       Date:  2016-10-03       Impact factor: 4.839

6.  Hypersomnia in Mood Disorders: a Rapidly Changing Landscape.

Authors:  David T Plante
Journal:  Curr Sleep Med Rep       Date:  2015-06

7.  Development and validation of the Hypersomnia Severity Index (HSI): A measure to assess hypersomnia severity and impairment in psychiatric disorders.

Authors:  Katherine A Kaplan; David T Plante; Jesse D Cook; Allison G Harvey
Journal:  Psychiatry Res       Date:  2019-08-31       Impact factor: 3.222

Review 8.  Sleep propensity in psychiatric hypersomnolence: A systematic review and meta-analysis of multiple sleep latency test findings.

Authors:  David T Plante
Journal:  Sleep Med Rev       Date:  2016-01-14       Impact factor: 11.609

9.  Subjective and Objective Measures of Hypersomnolence Demonstrate Divergent Associations with Depression among Participants in the Wisconsin Sleep Cohort Study.

Authors:  David T Plante; Laurel A Finn; Erika W Hagen; Emmanuel Mignot; Paul E Peppard
Journal:  J Clin Sleep Med       Date:  2016-04-15       Impact factor: 4.062

Review 10.  Hypersomnia and depressive symptoms: methodological and clinical aspects.

Authors:  Yves Dauvilliers; Régis Lopez; Maurice Ohayon; Sophie Bayard
Journal:  BMC Med       Date:  2013-03-21       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.